Business Context and Reporting Period
Company: HealthSouth Corporation (Note: The filing text identifies the registrant as HealthSouth Corporation, despite the request metadata referencing Encompass Health Corp, which was the name adopted later).
Reporting Period: Fiscal year ended December 31, 2005.
Business Overview: HealthSouth is the largest provider of ambulatory surgery and rehabilitative health care services in the United States, operating 1,070 facilities with approximately 37,000 employees. The company is in a multi-year turnaround phase following a major financial fraud scandal uncovered in 2002-2003 involving prior management. The 2005 reporting period focused on reconstructing accounting records, settling government investigations, and implementing a new strategic plan.
Key Financial Metrics
| Metric | 2005 | 2004 | 2003 |
|---|---|---|---|
| Net Operating Revenues | $3.21 billion | $3.51 billion | $3.66 billion |
| Net Loss | $(446.0) million | $(174.5) million | $(434.6) million |
| Loss from Continuing Operations | $(384.6) million | $(54.1) million | $(426.9) million |
| Consolidated Adjusted EBITDA | $629.1 million | $698.8 million | $682.8 million |
| Long-Term Debt (as of 12/31/05) | $3.40 billion | $3.50 billion | $3.50 billion |
| Cash and Cash Equivalents | $175.5 million | $449.1 million | $464.0 million |
| Shareholders' Deficit | $(1.54) billion | $(1.11) billion | $(963.8) million |
Material Changes vs. Prior Period
- Revenue Decline: Net operating revenues decreased 8.7% from 2004 to 2005. This was driven by volume decreases across all segments, particularly the Inpatient division due to the phase-in of the Medicare "75% Rule," and a change in ownership classification for two inpatient facilities which reduced reported revenue by approximately $106.3 million.
- Increased Net Loss: The net loss widened significantly to $446.0 million in 2005 compared to $174.5 million in 2004. This increase was primarily due to a $215.0 million charge for a proposed securities litigation settlement and higher interest expense, partially offset by a $37.9 million recovery of amounts due from a related party (Meadowbrook).
- EBITDA Decline: Consolidated Adjusted EBITDA decreased 10.0% to $629.1 million, reflecting declining volumes and increased operating expenses related to professional service fees.
- Debt Restructuring (Subsequent Event): On March 10, 2006, the company completed recapitalization transactions to prepay substantially all prior indebtedness and replace it with approximately $3 billion of new long-term debt, reducing refinancing risk and improving liquidity.
Guidance, Outlook, and Risks
- Outlook: Management expects 2006 Consolidated Adjusted EBITDA to decline substantially from 2005. This is due to the loss of a one-time $37.9 million recovery recorded in 2005 and the full-year impact of reduced Medicare unit pricing (IRF-PPS changes) which only affected one quarter in 2005.
- Strategic Plan: The company is in Phase 1 of a three-phase strategic plan focused on operational improvements, cost reduction, and mitigating the impact of the 75% Rule. Future phases will focus on growth and consolidation opportunities.
- Key Risks:
- Regulatory Changes: The "75% Rule" and reduced Medicare reimbursement rates continue to create a challenging operating environment for the Inpatient division, which generates the majority of revenues.
- Litigation: While a preliminary settlement of $215 million (stock and warrants) plus $230 million (insurance cash) has been reached for securities litigation, final court approval is pending. Ongoing DOJ investigations remain a risk.
- Internal Controls: Management concluded that internal controls over financial reporting were ineffective as of December 31, 2005, citing material weaknesses in financial close processes, journal entries, and IT controls.
- Leverage: The company remains highly leveraged, requiring a substantial portion of cash flow for debt service and government settlement payments.
Important Facts for Investor Verification
- Settlement Finality: Verify the final court approval status of the $215 million securities litigation settlement and the $325 million Medicare program settlement.
- Internal Control Remediation: Monitor progress on remediation of material weaknesses in internal controls, as this impacts the ability to file timely reports and access capital markets.
- 75% Rule Impact: Assess the actual volume impact of the Medicare 75% Rule on the Inpatient division in 2006 compared to management's estimates of a $30 million revenue reduction.
- Debt Covenants: Verify compliance with the new debt covenants established in the March 2006 recapitalization, specifically the interest coverage and leverage ratios.
- Divestiture Plans: Track the status of potential divestitures, including the Diagnostic division and the Digital Hospital project, which could impact future cash flows and debt reduction.